TLSA
NASD Tiziana Life Sciences Ltd.$1.15 ↑ +0.01 (+0.88%) Trading Up from the previous close of $1.14, $0.05 below the day’s high of $1.20
- YTD change
- -22.82%
- vs 20-day SMA
- +18.85%
- vs 200-day SMA
- -8.99%
Price ranges
Price & Performance
-0.11 (-8.80%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 90.6% away from all-time highs of $12.17
- TLSA is down 23% since the beginning of the year
- TLSA is down 43% over the past 12 months
- TLSA is up 23% over the past 1 month
- 2% of all TLSA investors are betting against TLSA
TLSA reads very good: price sits above one of the two key moving averages, the 12-month move is -43.0%.
- Previous minute
- +$0.01
- Last hour
- -$0.01
- Last 5 days
- +10.58%
- vs 8-day SMA
- +12.55%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.